文献

J-GLOBAL ID：201902230662366479   整理番号：19A2263952

転移性結腸直腸癌患者における第二選択療法としての隔週のCAPIRI+ベバシズマブの多施設第二相試験(JSWOG-C3研究)

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

著者 (20件)： Suzuki Nobuaki (Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan) ,  Hazama Shoichi (Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan) ,  Hazama Shoichi (Department of Translational Research and Developmental Therapeutics Against Cancer, Yamaguchi University School of Medicine, Ube, Japan) ,  Nagasaka Takeshi (Department of Clinical Oncology, Kawasaki Medical School, Kurashiki, Japan) ,  Tanioka Hiroaki (Department of Clinical Oncology, Kawasaki Medical School, Kurashiki, Japan) ,  Iwamoto Yasuo (Department of Medical Oncology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan) ,  Negoro Yuji (Department of Medical Oncology, Kochi Health Sciences Center, Kochi, Japan) ,  Yamauchi Masami (Division of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Japan) ,  Kobayashi Michiya (Cancer Treatment Center, Kochi Medical School Hospital, Kochi, Japan) ,  Okuda Hiroshi (Surgery and Endoscopic Surgery, Onomichi General Hospital, Onomichi, Japan) ,  Fujishima Noriaki (Department of Surgery, Fukuda Clinic of Internal Medicine, Heart and Digestive, Kochi, Japan) ,  Nishimura Taku (Department of Surgery, Kokura Memorial Hospital, Kokura, Japan) ,  Yamanaka Naoki (Department of Surgery, Japanese Red Cross Yamaguchi Hospital, Yamaguchi, Japan) ,  Toyota Kazuhiro (Department of Surgery, National Hospital Organization Higashihiroshima Medical Center, Hiroshima, Japan) ,  Mori Yoshiko (Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan) ,  Nakagami Yuki (Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan) ,  Nakagami Yuki (Department of Translational Research and Developmental Therapeutics Against Cancer, Yamaguchi University School of Medicine, Ube, Japan) ,  Shimokawa Mototsugu (Cancer Biostatistics Laboratory, Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan) ,  Nagano Hiroaki (Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan) ,  Okajima Masazumi (Department of Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan)
資料名： International Journal of Clinical Oncology (Web)  (International Journal of Clinical Oncology (Web))
巻： 24  号： 10  ページ： 1223-1230  発行年： 2019年 
JST資料番号： U1599A  ISSN： 1341-9625  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 3週間ごとのカペシタビン+イリノテカン(CAPIRI)は,転...

シソーラス用語： *大腸腫瘍 ,...
準シソーラス用語： *転移性結腸直腸癌 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2263952&from=J-GLOBAL&jstjournalNo=U1599A") }}

著者キーワード (5件)： ベバシズマブ ,  Capiri ,  隔週 ,  第2線 ,  MCRC

分類 (3件)： 腫ようの薬物療法  (GE03032C) ,  消化器の腫よう  (GH04000D) ,  抗腫よう薬の臨床への応用  (GW16020L)

物質索引 (2件)： カペシタビン ,  イリノテカン

タイトルに関連する用語 (8件)： 転移性結腸直腸癌 ,  患者 ,  第二選択療法 ,  ベバシズマブ ,  施設 ,  第二相試験 ,  C3 ,  研究